Showing results (1831-1840 of 1,918) with videos related to

Sort By:
Pageof 192
Diabetes|April 12, 2024
Depletion of TBC1D4 Improves the Metabolic Exercise Response by Overcoming Genetically Induced Peripheral Insulin ResistanceChristian Springer, Christian Binsch, Deborah Weide, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2017
Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma PatientsDennis Plenker, Miriam Bertrand, Adrianus J de Langen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2022
Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosisSynne Brune, Einar A Høgestøl, Sigrid A de Rodez Benavent, et al.
The New England Journal of Medicine|November 12, 2021
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart DiseaseAndrea Beaton, Emmy Okello, Joselyn Rwebembera, et al.
Neuroimage. Clinical|June 30, 2022
Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter studyHenning H Rise, Synne Brune, Claudia Chien, et al.
The Journal of Rheumatology|April 5, 2007
The OMERACT Ultrasound Group: status of current activities and research directionsRichard J Wakefield, Maria-Antonietta D'Agostino, Annamaria Iagnocco, et al.
Ebiomedicine|November 12, 2025
Blood-brain barrier opening as a predictor of epilepsy and mortality after subarachnoid haemorrhageJens P Dreier, Svetlana Lublinsky, Viktor Horst, et al.
Nature Communications|August 29, 2024
Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissueRichard D Bell, Matthew Brendel, Maxwell A Konnaris, et al.
Briefings in Bioinformatics|April 17, 2026
Translational bioinformatics stalls at implementationLars Rønn Olsen, Helene Scheel Wegener, Puck Quarles van Ufford, et al.
European Journal of Cancer (Oxford, England : 1990)|June 28, 2025
Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinomaViola K DeTemple, Martin Kaatz, Eggert Stockfleth, et al.
Pageof 192